Cluster analysis

Omada Sets New Industry Standard with Real-Time Identity Governance

Retrieved on: 
Wednesday, January 31, 2024
Cloud, Policy, ServiceNow, Administration, ITSM, Machine learning, IGA, Ecosystem, Identity, Cluster analysis, Mining, Next Generation, Connectivity, Software as a service, Video game

COPENHAGEN, Denmark, Jan. 31, 2024 /PRNewswire/ -- Omada A/S ("Omada"), a global leader of Identity Governance and Administration (IGA) Software-as-a-Service (SaaS), today introduced the next generation of Omada Identity Cloud, Horizons. Built on a modern, cloud-native microservice architecture, Omada will deliver unprecedented speed, intelligent decision support, connectivity and higher operational efficiency.

Key Points: 
  • The Next Generation of Omada Identity Cloud Delivers Speed, Intelligence, Connectivity and Efficiency with 10X Performance Boost
    COPENHAGEN, Denmark, Jan. 31, 2024 /PRNewswire/ -- Omada A/S ("Omada"), a global leader of Identity Governance and Administration (IGA) Software-as-a-Service (SaaS), today introduced the next generation of Omada Identity Cloud , Horizons.
  • Omada Identity Cloud will deliver enhanced performance for users, with the ability to import and process identity data faster than ever.
  • Connectivity for the Identity Fabric : Omada allows customers to easily configure any application and system to ensure end-to-end identity governance across the application estate and the larger ecosystem of identity and security solutions.
  • To learn more about the new Omada Identity Cloud release, tune into the webinar on Wednesday, January 31.

Omada Sets New Industry Standard with Real-Time Identity Governance

Retrieved on: 
Wednesday, January 31, 2024
Cloud, Policy, ServiceNow, Administration, ITSM, Machine learning, IGA, Ecosystem, Identity, Cluster analysis, Mining, Next Generation, Connectivity, Software as a service, Video game

COPENHAGEN, Denmark, Jan. 31, 2024 /PRNewswire/ -- Omada A/S ("Omada"), a global leader of Identity Governance and Administration (IGA) Software-as-a-Service (SaaS), today introduced the next generation of Omada Identity Cloud, Horizons. Built on a modern, cloud-native microservice architecture, Omada will deliver unprecedented speed, intelligent decision support, connectivity and higher operational efficiency.

Key Points: 
  • The Next Generation of Omada Identity Cloud Delivers Speed, Intelligence, Connectivity and Efficiency with 10X Performance Boost
    COPENHAGEN, Denmark, Jan. 31, 2024 /PRNewswire/ -- Omada A/S ("Omada"), a global leader of Identity Governance and Administration (IGA) Software-as-a-Service (SaaS), today introduced the next generation of Omada Identity Cloud , Horizons.
  • Omada Identity Cloud will deliver enhanced performance for users, with the ability to import and process identity data faster than ever.
  • Connectivity for the Identity Fabric : Omada allows customers to easily configure any application and system to ensure end-to-end identity governance across the application estate and the larger ecosystem of identity and security solutions.
  • To learn more about the new Omada Identity Cloud release, tune into the webinar on Wednesday, January 31.

WiMi Developed a Trimmed K-Means Algorithm to Detect Crypto Wallet Fraud on the Bitcoin Network

Retrieved on: 
Thursday, January 18, 2024
Cloud, Bitcoin, Holography, Anomaly, Fraud, Cluster analysis, Workflow, Behavior informatics, Environment, Symmetry, Acquisition, Blockchain, Trimmed, Engineering, Augmented reality, Data, WIMI, Cryptocurrency

Beijing, Jan. 18, 2024 (GLOBE NEWSWIRE) -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced a Trimmed K-Means algorithm for detecting crypto-wallet fraud on the Bitcoin network.

Key Points: 
  • Beijing, Jan. 18, 2024 (GLOBE NEWSWIRE) -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced a Trimmed K-Means algorithm for detecting crypto-wallet fraud on the Bitcoin network.
  • It combines symmetry and asymmetry in computer and engineering sciences to provide a novel solution for crypto-wallet fraud on the Bitcoin network.
  • First, through the collective anomaly detection method, anomalous behaviors can be identified more efficiently on the Bitcoin network, improving the overall security of the network.
  • Second, the Trimmed K-Means algorithm is used to reduce the processing cost of feature extraction, making it more practical.

WiMi Developed An Integrated Multidisciplinary Algorithm-----MultiFeatureEvoCluster

Retrieved on: 
Wednesday, November 29, 2023
Cloud, Euclidean, Research, Organization, Augmented reality, Strategic planning, Data analysis, Cluster analysis, Holography, WIMI, Knowledge, Mobile phone, Rolling (metalworking)

BEIJING, Nov. 29, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed an integrated multidisciplinary algorithm for clustering heterogeneous datasets, namely, MultiFeatureEvoCluster technology, which not only effectively handles multi-featured datasets, but also assigns explicit semantic meanings to the clustering results.

Key Points: 
  • BEIJING, Nov. 29, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed an integrated multidisciplinary algorithm for clustering heterogeneous datasets, namely, MultiFeatureEvoCluster technology, which not only effectively handles multi-featured datasets, but also assigns explicit semantic meanings to the clustering results.
  • The technology integrates advanced techniques and methods from multiple subject areas to ensure efficient processing and accurate clustering of complex datasets.
  • Behind the development of MultiFeatureEvoCluster is a multidisciplinary team focused on data analysis and algorithmic innovation, consisting of data experts, statistical specialists and computer scientists.
  • Facing the data challenges of the digital era, WiMi has introduced MultiFeatureEvoCluster technology that brings new opportunities and possibilities to enterprises.

Databloom AI Announces Beta Release of Blossom Sky in Google Cloud

Retrieved on: 
Wednesday, August 16, 2023
Cloud, Data management, Software as a service, Partnership, VDL, Google Cloud Platform, Software, Cluster analysis, Organization, Complexity, Machine learning, Map, Google Cloud, Federated, Growth, ETL, SGD, PageRank, Filter, Network equipment provider, Satellite navigation device, Sales

MIAMI, Aug. 16, 2023 /PRNewswire/ -- DataBloom AI, a leading provider of virtual data lakehouse solutions, today announced the beta release of Blossom Sky for Google Cloud. The beta release is part of Databloom AI's cooperation with Google for Startups Cloud Program.

Key Points: 
  • Blossom Sky Shapes Data's Future: The Virtual Data Lakehouse on Google Cloud
    MIAMI, Aug. 16, 2023 /PRNewswire/ -- DataBloom AI, a leading provider of virtual data lakehouse solutions, today announced the beta release of Blossom Sky for Google Cloud.
  • The beta release is part of Databloom AI's cooperation with Google for Startups Cloud Program.
  • "We are excited to partner with Google Cloud to bring Blossom Sky to market," said Alexander Alten, CEO of Databloom AI.
  • The beta release of Blossom Sky in Google Cloud is available now.

Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID

Retrieved on: 
Monday, August 7, 2023
Tonix Pharmaceuticals, Therapy, Arthralgia, Cluster analysis, Sleep, DSM-IV codes, SL, Brain, Infection, COVID, CFS/ME, Bangladesh Technical Education Board, Quality, Pain, Myalgia, Back pain, Translational medicine, Patient, Quality of life, Fibromyalgia, National Institute of Allergy and Infectious Diseases, NIAID, FDA, CFS, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NIH, Food, Fatigue, Pharmaceutical industry, Long COVID

CHATHAM, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company, today announced the completion of the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL as a potential treatment for fibromyalgia-type Long COVID. Topline results for the PREVAIL study are expected in the third quarter of 2023.

Key Points: 
  • “Approximately 40% of U.S. Long COVID patients have fibromyalgia-like multi-site pain symptoms based on our observational studies of Long COVID patients from the TriNetX claims database,”2,3 said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals.
  • We have termed this subgroup, ‘Fibromyalgia-type Long COVID.’ Given our encouraging results with TNX-102 SL as a potential treatment for fibromyalgia4, we are testing TNX-102 SL as a bedtime medicine for the management of Fibromyalgia-type Long COVID.
  • In their recent publication, cluster analysis of the symptom frequencies in the RECOVER study identified four subgroups of Long COVID patients.
  • We believe that daily pain has the potential to be an endpoint for registrational studies in fibromyalgia-like long COVID.”

Tonix Pharmaceuticals Comments on Two Long COVID Conferences Sponsored by the U.S. National Academies

Retrieved on: 
Thursday, July 6, 2023
Database, Tonix Pharmaceuticals, Arthralgia, Cluster analysis, SARS-CoV-2, National Academies of Sciences, Engineering, and Medicine, Sleep, DSM-IV codes, SL, Infection, COVID, Bangladesh Technical Education Board, Quality, Pain, Myalgia, National academy, Back pain, Nociplastic pain, Hydrogen chloride, Translational medicine, Patient, Quality of life, Motivation, Fibromyalgia, National Institute of Allergy and Infectious Diseases, NIAID, Research, FDA, CFS, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Fatigue, Pharmaceutical industry, Long COVID, Engineering, Medicine

CHATHAM, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company, today announced comments relating to two recent meetings sponsored by the National Academies of Sciences, Engineering, and Medicine (National Academies) in Washington, D.C. and virtually, relating to the definition of Long COVID and to features of Long COVID that overlap with previously recognized infection-associated chronic conditions. The first meeting, “Examining the Working Definition for Long COVID”1, took place on June 22 and 23, and the second, “Toward a Common Research Agenda in Infection-Associated Chronic Illnesses”2 took place on June 29 and 30. Tonix Pharmaceuticals recognizes the potential benefits of defining subgroups of Long COVID patients based on their symptoms and recognizes the subgroup of Long COVID patients with symptoms that overlap with fibromyalgia. Tonix’s experience advancing TNX-102 SL (cyclobenzaprine HCl sublingual tablets)* as a treatment for fibromyalgia is the Company’s motivation for undertaking the development of TNX-102 SL for the management of Fibromyalgia-type Long COVID.

Key Points: 
  • CHATHAM, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company, today announced comments relating to two recent meetings sponsored by the National Academies of Sciences, Engineering, and Medicine (National Academies) in Washington, D.C. and virtually, relating to the definition of Long COVID and to features of Long COVID that overlap with previously recognized infection-associated chronic conditions.
  • Tonix Pharmaceuticals recognizes the potential benefits of defining subgroups of Long COVID patients based on their symptoms and recognizes the subgroup of Long COVID patients with symptoms that overlap with fibromyalgia.
  • Tonix’s experience advancing TNX-102 SL (cyclobenzaprine HCl sublingual tablets)* as a treatment for fibromyalgia is the Company’s motivation for undertaking the development of TNX-102 SL for the management of Fibromyalgia-type Long COVID.
  • We believe Cluster #4 is a subgroup of Long COVID that overlaps with fibromyalgia.

Arize AI Launches Industry-First LLM Observability Tool

Retrieved on: 
Thursday, May 18, 2023
RCA, LLM, Hallucination, Cluster analysis, ChatGPT, Prompt engineering, Risk, Machine learning, Fine-tuning, Algorithm, Engineering, Entrepreneurship, Risk management, Management, Arize

BERKELEY, Calif., May 18, 2023 /PRNewswire/ -- Arize AI, a market leader in machine learning observability, debuted new capabilities for fine tuning and monitoring large language models (LLMs) today. The offering brings greater control and insight to teams looking to build with LLMs.

Key Points: 
  • BERKELEY, Calif., May 18, 2023 /PRNewswire/ -- Arize AI, a market leader in machine learning observability, debuted new capabilities for fine tuning and monitoring large language models (LLMs) today.
  • Now available as part of the free product, Arize's LLM observability tool is the first to evaluate LLM responses, pinpoint where to improve with prompt engineering, and identify fine-tuning opportunities using vector similarity search.
  • Detect Problematic Prompts and Responses: By monitoring a model's prompt/response embeddings performance using LLM evaluation scores and cluster analysis, teams can narrow in on areas their LLM needs improvement.
  • "As new applications get built, Arize LLM observability is here to provide the right guardrails to innovate with this new technology safely."

Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform

Retrieved on: 
Wednesday, April 12, 2023
Technology, Biotechnology, Audio, Video, Health, Biometrics, Other Health, Oncology, Other Technology, Research, General Health, Health Technology, Hardware, Science, Data Management, Cloud, Partnership, AACR, Doctor of Philosophy, Cluster analysis, American Association for Cancer Research, Multimedia, HDR, Proteomics, Medicine, Medical imaging, Canopy

Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology.

Key Points: 
  • Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology.
  • The partnership will add to the analytic capabilities of the CellScape system by providing options to use Enable Medicine’s advanced spatial analyses, including cluster analysis, neighborhood analysis and advanced data visualization, as well as efficient cloud-based computing, sharing, and data storage.
  • Enable Medicine’s Enable Cloud platform accelerates biological insights via advanced spatial analytics and cloud-based workflows for spatial biology.
  • Integrating the Enable Cloud Platform into the CellScape system promises to significantly enhance and streamline analysis for discovery and translational research applications.

IronYun expands the power of the Vaidio® AI Vision Platform with 7.0 Release

Retrieved on: 
Thursday, March 23, 2023
Metadata, Cluster analysis, The Scene Changes: The Amazing Bud Powell (Vol. 5), Recognition, Snow, Lowell Observatory Near-Earth-Object Search, Version 7.0: The Street Scriptures, LPR, HTTP, NVR, Safety, Mobile phone, Video game, AI

STAMFORD, Conn., March 23, 2023 /PRNewswire/ -- IronYun Inc., a leader in AI vision for security, safety, and operational applications, today announced the 7.0 release of the Vaidio® AI Vision Platform. The award-winning Vaidio Platform now includes Object Counting, federated Object Search, and enhancements to Scene Change, Fall Detection, Vaidio Data, and more.

Key Points: 
  • Vaidio 7.0 enhances Object Search, Object Counting, Scene Change, Vaidio Data and more
    STAMFORD, Conn., March 23, 2023 /PRNewswire/ -- IronYun Inc., a leader in AI vision for security, safety, and operational applications, today announced the 7.0 release of the Vaidio® AI Vision Platform.
  • The award-winning Vaidio Platform now includes Object Counting, federated Object Search, and enhancements to Scene Change, Fall Detection, Vaidio Data, and more.
  • The Vaidio AI Vision Platform is an open platform that layers advanced AI-enabled video analytics onto existing IP cameras and video infrastructures.
  • "Rapid development is vital to addressing the dynamic video analytics needs of our clients in every sector," said Paul Sun, CEO of IronYun.